Novel Drug Reduced Bulging in Active and Chronic Thyroid Eye Disease

By News Health
2 months Ago

(MedPage Today) — ORLANDO — Infusions of the investigational monoclonal antibody veligrotug improved symptoms among patients with active and chronic thyroid eye disease, the phase III THRIVE clinical program showed.
By week 15 in 113 patients…

Source link : https://www.medpagetoday.com/meetingcoverage/aace/115658

Author :

Publish date : 2025-05-19 19:34:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

At-Home Alzheimer’s Testing Is Here: Are Physicians Ready?

An Elusive PCOS Diagnosis Could Explain Obesity Issues

Are You Asking These Seven Sexual Health Questions?

Direct Challenge Safe for Penicillin Allergy in Pregnancy

Woman smuggled baby into UK using fake birth story

Asthma Amplifies Allergic Rhinitis Burden in Children